NCT00532233View on ClinicalTrials.gov

SD, IL-13 Production Rate in IPF

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

QAX576

Trial Locations (6)

15213

Novartis Investigative Site, Pittsburgh

27704

Novartis Investigative Site, Durham

30319

Novartis Investigative Site, Atlanta

55905

Novartis Investigative Site, Rochester

70112

Novartis Investigative Site, New Orleans

80206

Novartis Investigative Site, Denver

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY